tm logo
THE HIT TECHNOLOGY
Dead/Cancelled
CANCELLED - SECTION 8

section 8

on 22 Jan 2005

Last Applicant/ Owned by

2425 Skymark Avenue

Mississauga, Ontario

CA

L4W 4Y6

Serial Number

74593427 filed on 01st Nov 1994

Registration Number

2151579 registered on 21st Apr 1998

in the Principal Register

Correspondent Address

IVOR M HUGHES

HUGHES ETIGSON

175 COMMERCE VALLEY DR W STE 200

THORNHILL ONTARIO CANADA L3T 7P6

Filing Basis

No Filing Basis

Disclaimer

"TECHNOLOGY"

THE HIT TECHNOLOGY

pharmaceutical preparations comprising hyaluronan, adapted for the topical, injectable, and intravenous treatment of the following - cancer, increasing activity of macrophages; reduction of swelling in the brain of person suffering brain trauma; herpes, canker sore, shingles; renal failure, cardiac insufficiency, hypertension, edema; infection, acne, monoucleosis; transplants; inflammation, elminaRead More

Classification Information


Class [005]
Pharmaceutical Products


pharmaceutical preparations comprising hyaluronan, adapted for the topical, injectable, and intravenous treatment of the following - cancer, increasing activity of macrophages; reduction of swelling in the brain of person suffering brain trauma; herpes, canker sore, shingles; renal failure, cardiac insufficiency, hypertension, edema; infection, acne, monoucleosis; transplants; inflammation, elmination of tumor breakdown material (toxins and debris), decreasing side effects, relief of pain; detoxification; broncholdilation; vascular ischemia; HIV (AIDS); diabetes; post-menopause; prevention of topical infection; reduction of swelling; hypertension, cardiac insufficiency; prostaglandin synthesis inhibition; enhancement of oxygenation of tissue by perfusion fluid bathing of the tissue (for transplantation purposes); sub-retinal neovascularization and as an adjunct to the treament of cancer to prevent metastasis; arthitis or pannus; cancer tumours; inhibiting angiogenesis; controlling angiogenesis; regressing angiogenesis; basal cell carcinoma; actinic keratoses; liver spots; squamous cell tumours; metastatic cancer of the breast to the skin; primary and metastatic melanoma of the skin; malignancies and/or tumour of the skin; genital warts (condyloma acuminata); cervical cancer; Human Papilloma Virus (HPV); psoriasis, corns on the feet; and hair loss on the heads of pregnant women; topical treatment of pain in the skin and or exposed tissue; clearing of atherosclerosis; prevention of arterial restenosis after balloon angioplasty; macrophage infilitration

Class [042]
Computer & Software Services & Scientific Services


licensing of the intellectual property technology and researching and developing for others, regarding pharmaceutical preparations comprising hyaluronan, adapted for topical, injectible, and intravenous treatment of medical conditions and disease in humans

Mark Details


Serial Number

No 74593427

Mark Type

No Service Mark

Attorney Docket Number

No TM.1813

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
22nd Jan 2005CANCELLED SEC. 8 (6-YR)
21st Apr 1998REGISTERED-PRINCIPAL REGISTER
27th Jan 1998PUBLISHED FOR OPPOSITION
26th Dec 1997NOTICE OF PUBLICATION
20th Nov 1997APPROVED FOR PUB - PRINCIPAL REGISTER
01st Oct 1997CORRESPONDENCE RECEIVED IN LAW OFFICE
04th Sep 1997FINAL REFUSAL MAILED
24th Jul 1997CORRESPONDENCE RECEIVED IN LAW OFFICE
07th Jan 1997INQUIRY AS TO SUSPENSION MAILED
23rd Sep 1996INQUIRY AS TO SUSPENSION MAILED